Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PL-2200 vs Aspirin GI Safety in Healthy Volunteers
NCT00872534Phase 2Completed
- Sponsor
- PLx Pharma Inc.
- Start
- Jan 2009
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of omecamtiv mecarbil in cardiovascular disease (CVD), sponsored by PLx Pharma Inc.. Started Jan 2009; status: completed.
02
Drugs
omecamtiv mecarbil
03
Conditions
cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT00872534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00872534.